Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05838638 · ClinicalTrials.gov registry record · NA

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

A NA study of Neoplasms and Chemotherapy-induced Nausea and Vomiting, sponsored by University of Central Florida.

Recruiting
Registry status
NA
Development phase
610
Enrollment target
2
Study locations

NCT05838638 is a NA study of Neoplasms and Chemotherapy-induced Nausea and Vomiting that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 610 participants, below the 1,617-participant average among 158 other Neoplasms trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05838638, a NA study of Neoplasms and Chemotherapy-induced Nausea and Vomiting, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
NA
Development phase
610 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Interventions

  • BEHAVIORAL eSSET-CINV

Study Locations (2)

Florida

  • Miller School of Medicine Sylvester Comp. Cancer Center - Miami
  • Orlando Health - Orlando

Trial Details

FieldValue
Enrollment Target 610 participants
Start Date 2023-06-09
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT05838638

The ClinicalTrials.gov registry entry for NCT05838638 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,617-participant average among 158 other Neoplasms trials with a reported enrollment target (62% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which eSSET-CINV is the first listed.

NCT05838638 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05838638 about?

NCT05838638 is a clinical study titled "Serious Gaming for Chemotherapy-induced Nausea and Vomiting". The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use ...

What is the current status of trial NCT05838638?

This trial is currently recruiting. It is a NA study. The enrollment target is 610 participants. The study started on 2023-06-09. Estimated completion is 2027-06-30.

What conditions does trial NCT05838638 study?

This clinical trial studies the following conditions: Neoplasms, Chemotherapy-induced Nausea and Vomiting.

What interventions are being tested in trial NCT05838638?

The interventions under investigation include: eSSET-CINV (BEHAVIORAL).

Who is sponsoring clinical trial NCT05838638?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05838638 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.